Canadian Biotech Delivering Solutions to Global Marketplace

Reinventing traditional industries, Canadian innovation on display at BIO World Congress on Industrial Biotechnology in Montreal July 24-26

OTTAWA, Ontario--()--Today’s global population is closing in on the 7 billion mark. By 2050 it is predicted to grow to over 9 billion people. This exponential growth brings with it enormous challenges as 9 billion people will require new medicines, food, energy, and material goods. This growth and its corresponding demands, require more efficient and effective ways to deliver health care, grow food and manufacture goods. There is enormous opportunity for Canada’s biotechnology industry and the innovative solutions it represents.

“As a whole we must re-engineer our economies, along with our partners including governments. Biotech innovation is the key to the re-engineering process.”

“Canadian entrepreneurs have built companies using sugars to grow bio-based green chemicals for plastics, and a technology that captures carbon dioxide from coal-fired plants, developing solutions for the growing global population. The impact of a changing climate on crop growth and increased consumer concerns about food safety, health and nutrition present new opportunities requiring customized solutions,” commented Andrew Casey, President and CEO BIOTECanada. “As a whole we must re-engineer our economies, along with our partners including governments. Biotech innovation is the key to the re-engineering process.”

Importantly, biotechnology is becoming more central to supporting the economic and environmental transformation of Canada’s traditional economic cornerstone and job intensive industries, namely: forestry; energy; mining; agriculture; aerospace; manufacturing and resource management. Biotechnology innovation will support these sectors as they transform and compete in the emerging global bio-economy.

KEY EVENT:
Title: Global Partnerships to build value chains and transatlantic opportunities in the Bioeconomy

When: Tuesday July 25, 2017
6:45 AM – 8:30 AM
Palais des Congress, Montreal

The panel discussion will be focused on promoting research and industrial partnerships for Canadian participants. It will provide an opportunity to learn about how Canadian SMEs, global multinational enterprises and researchers can partner on industrial biotechnology projects, resulting in increased corporate innovation, increased trade, export and inward investment into Canada.

Panelists include:
Sandy Marshall, BioIndustrial Innovation Canada
Dirk Carrez, Executive Director, Biobased Industries Consortium
Evan Price, CEO, CO2 Solutions
Mark Kirby, CEO, S2G BioChem

Contacts

BIOTECanada
Nadine Lunt, 613-230-5585 x257

Recent Stories

RSS feed for BIOTECanada

Website